SG-608

N/A

Report date: 2025/01/26 15:10:23
NME

Base Information

Drug NameSG-608
Drug Alias NameAnti-miR-210 therapy (SomaGenics/LayerBio)Hypoxia inducible factor-1 alpha stimulator (SomaGenics/LayerBio)HIF-1 alpha stimulator (SomaGenics/LayerBio)SG-608
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionHypoxia-inducible factor 1 alpha stimulants
TargetsHypoxia-inducible factor 1 alpha
Therapy Area/IndicationsWounds and Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSomaGenics
China Registration ClassN/A

Develop Information

Active CompaniesLayerbio IncSomaGenics
Inactive CompaniesN/A
Active IndicationsWounds and Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A